SC 13D Filing

Company

COSCIENS Biopharma Inc.

Filed

May 12, 2003

Accession Number

0001214765-03-000006

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →